Illuminate Therapeutics
PrivateLast Round
Seed
Jun 1, 2025
Total Funding Raised
$75,000
Company Overview
Illuminate Therapeutics operates in Healthcare & Life Sciences and is based in Pennsylvania. Its latest recorded funding round was a Seed round in June 2025.
Illuminate Therapeutics is a biotechnology company developing a light-activated drug delivery and release (LADDR) platform for the targeted treatment of oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illuminate Therapeutics Comparables
Compare Illuminate Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Covalt Bio | 93% | |
| GenLumina | 84% | |
| LightOx Ltd | 73% |
For institutional investors. Book with your work email.
Illuminate Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2025 | ||||
| Grant | Apr 29, 2022 |
For institutional investors. Book with your work email.
Illuminate Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| General Inception | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Raised Seed round with General Inception as an investor.
- Apr 29, 2022
$75K grant round closed.
For institutional investors. Book with your work email.
Illuminate Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Illuminate Therapeutics's valuation, stock price, and market status.
Is Illuminate Therapeutics a public or private company?
Illuminate Therapeutics is a private company.
What is the current stock price of Illuminate Therapeutics?
Illuminate Therapeutics is a private company, so its shares have no public market price. Caplight tracks Illuminate Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Illuminate Therapeutics worth (valuation)?
Valuation information for Illuminate Therapeutics is not publicly available.
Can I buy Illuminate Therapeutics stock?
Illuminate Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Illuminate Therapeutics's last funding round?
Illuminate Therapeutics's most recent funding round was Seed on June 1, 2025.
Who are the main investors in Illuminate Therapeutics?
Key investors in Illuminate Therapeutics include General Inception.
Will Illuminate Therapeutics IPO soon?
No public IPO plans have been announced for Illuminate Therapeutics.
How can I track Illuminate Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Illuminate Therapeutics's shares on secondary markets.